Novartis reveals changes to executive committee
16 May 2018 -

Group General Counsel of Novartis (VTX: NOVN), Felix R. Ehrat, has announced his retirement, the multinational pharmaceutical company disclosed on Wednesday.

Current Chief Ethics, Risk and Compliance Officer, Shannon Thyme Klinger, will be appointed Group General Counsel, effective 1 June.

Ehrat's decision to retire comes in the context of discussions surrounding the company's former agreement with Essential Consultants, owned by Michael Cohen. While Ehrat, who has been Group General Counsel and a member of the executive committee since 2011, acknowledged that the contract was legally in order, he said there was an error and that, as co-signatory with the former CEO, took personal responsibility to bring the public debate on the matter to an end.

Klinger became Chief Ethics, Risk and Compliance Officer and Global Head of Litigation in 2016, and joined the executive committee earlier this year. She joined the company in 2011, where she served as General Counsel, North America, Sandoz US. She was then appointed Global Head of Legal and General Counsel for Sandoz.

Prior to joining Novartis, Klinger was a litigation partner at Mayer Brown LLP and Alston & Bird LLP. She also served as senior vice president and General Counsel at Solvay Pharmaceuticals Inc.